Jun 22nd, 2021
Evofem Biosciences CEO on Birth Control Gel Phexxi
Saundra Pelletier, chief executive officer of Evofem Biosciences Inc., talks about the Phexxi, a new birth control gel that is the first non-hormonal contraceptive to win FDA approval in decades. The approval last year marked a rare new option in the contraceptive market, which has been dominated by pills for the past 60 years. Pelletier speaks on "Bloomberg: Quicktake the Lead" (Source: Bloomberg)
